UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 27

of 'Immunotherapy of advanced melanoma with immune checkpoint inhibition'

27
TI
Nivolumab plus ipilimumab in patients with advanced melanoma: updated survival, response, and safety data in a phase I dose-escalation study
AU
Callahan MK, Kluger H, Postow MA, et al
SO
J Clin Oncol. 2017;
 
AD